{
  "report_rows": [
    {
      "kpi": "Q2 2026 Gross Bookings",
      "prediction": "IN-LINE",
      "answer": "pred ~$57.6B vs. cons $57.2B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 Non-GAAP EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.85 vs. cons $0.83",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$2.82B vs. cons $2.77B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Gross Bookings",
      "prediction": "UNCHANGED",
      "answer": "guide ~$59.7B vs. cons $59.5B (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP EPS",
      "prediction": "LOWER",
      "answer": "guide ~$0.86 vs. cons $0.89 (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.6,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.8,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Q2 beats are outweighed by Q3 EPS guidance of ~$0.86 vs. consensus $0.89; the day-5 residual reaches about -4.8% vs. -3.6% on day 1 as out-period estimates fall and AV/M&A investment concerns reinforce the cuts.",
  "day5_confidence": "MEDIUM"
}